AEON Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AEON Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • AEON Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.35M, a 317% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.35M +$1.02M +317% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.4M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $198K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $262K -$213K -44.8% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $323K Sep 30, 2023 10-Q/A 2024-03-29
Q4 2022 $475K Dec 31, 2022 10-K/A 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.